PAPHOS, Cyprus and TORONTO, Oct. 14, 2025 /PRNewswire/ -- Aims of the Partnership: Combine strategic business consulting with actionable sales…
Remedy Robotics has been selected by the Australian Stroke Alliance as its exclusive robotics partner to expand access to endovascular thrombectomy,…
AUSTIN, Texas and TOKYO, Oct. 13, 2025 /PRNewswire/ -- The global nanomedicine market size reached US$ 169.51 Billion in 2024…
HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on October…
NEWTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient…
NEW HAVEN, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company pioneering the use…
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a…
NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Gerstman PLLC is proud to announce that the New Jersey Department of Health…
Cognivia Signal expected to reduce trial dropout risk and placebo impact for pharma and biotech trial sponsors. MONT-SAINT-GUIBERT, Belgium, Oct.…